Back

Role of comorbidities in antithrombotic therapy selection.

31 August 2020 (10:30 - 10:40)
Organised by:
Congress Presentation Part of: Racial and Cultural Differences in anti-Thrombotic Therapy between Europe and Asia Stroke ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
AFIRE trial: “less is more” lesson from Japan to the world.
Doctor S. Yasuda (Sendai, JP)
Slides Video
Presentation thumbnail
Balancing stroke and bleeding risks in Asian patients with atrial fibrillation.
Doctor M. Akao (Kyoto, JP)
Slides Video
Presentation thumbnail
Pharmacogenomics in antithrombotic therapy: ready for prime time?
Professor J. Hulot (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Racial and Cultural Differences in anti-Thrombotic Therapy between Europe and Asia

The Event

Event poster

ESC Congress 2020

31 August 2020 10:30 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Insights into the comorbidity profile of atrial fibrillation patients from the EORP databases
7 April 2024
thumbnail
Webinar
Anticoagulation challenges in older subjects with multimorbidity
25 July 2023
thumbnail
Congress Presentation
Antithrombotic therapy in patients with ACS: default and alternative strategies
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources